{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:30:13Z","timestamp":1793853013702,"version":"4.6.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10072-020-04645-6","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:03:33Z","timestamp":1599134613000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Migraine and rare neurological disorders"],"prefix":"10.1007","volume":"41","author":[{"given":"Emma","family":"Scelzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ornello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio Agostino","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bersano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"4645_CR1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMcp1605502","volume":"377","author":"A Charles","year":"2017","unstructured":"Charles A (2017) Migraine. N Engl J Med 377:553\u2013561","journal-title":"N Engl J Med"},{"key":"4645_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","volume":"2","author":"A Charles","year":"2018","unstructured":"Charles A (2018) Pathophysiology of migraine: implications for clinical management. Lancet Neurol 2:174\u2013182","journal-title":"Lancet Neurol"},{"key":"4645_CR3","first-page":"1","volume":"38","author":"Headache Classification Committee of the International Headache Society [IHS]","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society [IHS] (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1\u2013211","journal-title":"Cephalalgia"},{"key":"4645_CR4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0039-1700525","volume":"39","author":"CL Fraser","year":"2019","unstructured":"Fraser CL, Hepschke JL, Jenkins B, Prasad S (2019) Migraine aura: pathophysiology, mimics, and treatment options. Semin Neurol 39:739\u2013748","journal-title":"Semin Neurol"},{"key":"4645_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-018-0676-y","volume":"40","author":"R Ramachandran","year":"2018","unstructured":"Ramachandran R (2018) Neurogenic inflammation and its role in migraine. Semin Immunopathol 40:301\u2013314","journal-title":"Semin Immunopathol"},{"key":"4645_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s10194-019-1017-9","volume":"20","author":"HG Sutherland","year":"2019","unstructured":"Sutherland HG, Albury CL, Griffiths LR (2019) Advances in genetics of migraine. J Headache Pain 20:72","journal-title":"J Headache Pain"},{"key":"4645_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/WCO.0000000000000687","volume":"32","author":"I de Boer","year":"2019","unstructured":"de Boer I, van den Maagdenberg AMJM, Terwindt GM (2019) Advance in genetics of migraine. Curr Opin Neurol 32:413\u2013421","journal-title":"Curr Opin Neurol"},{"key":"4645_CR8","doi-asserted-by":"crossref","unstructured":"Liem MK, Oberstein SA, van der Grond J, Ferrari MD, Haan J (2010) CADASIL and migraine: a narrative review. Cephalalgia:1284\u20131289","DOI":"10.1177\/0333102410370870"},{"key":"4645_CR9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ana.410440506","volume":"44","author":"M Dichgans","year":"1998","unstructured":"Dichgans M, Mayer M, Uttner I, Br\u00fcning R, M\u00fcller-H\u00f6cker J, Rungger G, Ebke M, Klockgether T, Gasser T (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44:731\u2013739","journal-title":"Ann Neurol"},{"key":"4645_CR10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/0333102415620909","volume":"36","author":"S Guey","year":"2015","unstructured":"Guey S, Mawet J, Herve D, Duering M, Godin O, Jouvent E et al (2015) Prevalence and characteristics of migraine in CADASIL. Cephalalgia 36:1038\u20131047","journal-title":"Cephalalgia"},{"key":"4645_CR11","doi-asserted-by":"crossref","first-page":"e0157613","DOI":"10.1371\/journal.pone.0157613","volume":"11","author":"R Tan","year":"2016","unstructured":"Tan R, Markus H (2016) CADASIL: migraine, encephalopathy, stroke and their inter-relationships. PLoS ONE 11:e0157613","journal-title":"PLoS ONE"},{"key":"4645_CR12","first-page":"1237","volume":"61","author":"K Vahedi","year":"2004","unstructured":"Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser M (2004) Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch NeurolArch Neurol 61:1237\u20131240","journal-title":"Arch NeurolArch Neurol"},{"key":"4645_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/STROKEAHA.111.631028","volume":"43","author":"B Gunda","year":"2011","unstructured":"Gunda B, Herve D, Godin O et al (2011) Effects of gender on the phenotype of CADASIL. Stroke 43:137\u2013141","journal-title":"Stroke"},{"key":"4645_CR14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","volume":"8","author":"H Chabriat","year":"2009","unstructured":"Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) Cadasil. Lancet Neurol 8:643\u2013653","journal-title":"Lancet Neurol"},{"key":"4645_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11916-016-0584-6","volume":"20","author":"S Zhu","year":"2016","unstructured":"Zhu S, Nahas S (2016) CADASIL: imaging characteristics and clinical correlation. Curr Pain Headache Rep 20:57","journal-title":"Curr Pain Headache Rep"},{"key":"4645_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11940-017-0468-z","volume":"19","author":"A Bersano","year":"2017","unstructured":"Bersano A, Bedini G, Oskam J, Mariotti C, Taroni F, Baratta S, Parati EA (2017) CADASIL: treatment and management options. Curr Treat Options Neurol 19:31","journal-title":"Curr Treat Options Neurol"},{"key":"4645_CR17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ng2082","volume":"39","author":"A Richards","year":"2007","unstructured":"Richards A, van den Maagdenberg AM, Jen JC et al (2007) C-terminal truncations in human 3'\u20135' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 39:1068\u20131070","journal-title":"Nat Genet"},{"key":"4645_CR18","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/brain\/aww217","volume":"139","author":"A Stam","year":"2016","unstructured":"Stam A, Kothari HP, Shaikh A, Gschwendter A, Jen JC, Hodgkinson S et al (2016) Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain 139:2909\u20132922","journal-title":"Brain"},{"key":"4645_CR19","doi-asserted-by":"crossref","unstructured":"Pelzer N, Hoogeveen ES, Haan J, Bunnik R, Poot CC, van Zwet EW, Inderson A, Fogteloo AJ, Reinders MEJ, Middelkoop HAM, Kruit MC, van den Maagdenberg AMJM, Ferrari MD, Terwindt GM (2019) Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease. J Intern Med:317\u2013332","DOI":"10.1111\/joim.12848"},{"key":"4645_CR20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1212\/WNL.53.3.629","volume":"53","author":"S Weil","year":"1999","unstructured":"Weil S, Reifenberger G, Dudel D, Yousry TA, Schriever S, Noachtar S (1999) Cerebroretinal vasculopathy mimicking a brain tumor: a case of a rare hereditary syndrome. Neurology 53:629\u2013631","journal-title":"Neurology"},{"key":"4645_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10072-014-1944-9","volume":"36","author":"JC DiFrancesco","year":"2014","unstructured":"DiFrancesco JC, Novara F, Zuffardi O et al (2014) TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. Neurol Sci 36:323","journal-title":"Neurol Sci"},{"key":"4645_CR22","unstructured":"Plaisier E, Ronco P (2009) COL4A1-related disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A. GeneReviews\u00ae. Seattle: University of Washington, Seattle; 1993\u20132020"},{"key":"4645_CR23","doi-asserted-by":"crossref","unstructured":"Bersano A, Kraemer M, Burlina A, Mancuso M, Finsterer J, Sacco S, Salvarani C, Caputi L, Chabriat H, Oberstein SL, Federico A, Lasserve ET, Hunt D, Dichgans M, Arnold M, Debette S, Markus HS (2020) Heritable and non-heritable uncommon causes of stroke. J Neurol 2020 Apr 21","DOI":"10.1007\/s00415-020-09948-4"},{"key":"4645_CR24","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1161\/STROKEAHA.110.581918","volume":"41","author":"S Lanfranconi","year":"2010","unstructured":"Lanfranconi S, Markus HS (2010) COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 41:e513\u2013e518","journal-title":"Stroke"},{"key":"4645_CR25","doi-asserted-by":"crossref","first-page":"e2078","DOI":"10.1212\/WNL.0000000000006567","volume":"9","author":"S Zagaglia","year":"2018","unstructured":"Zagaglia S, Selch C, Nisevic JR, Mei D, Michalak Z, Hernandez-Hernandez L et al (2018) Neurologic phenotypes associated with COL4A1\/2 mutations: expanding the spectrum of disease. Neurology 9:e2078\u2013e2088","journal-title":"Neurology"},{"key":"4645_CR26","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa053727","volume":"354","author":"DB Gould","year":"2006","unstructured":"Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, Bousser MG, Heutink P, Miner JH, Tournier-Lasserve E, John SWM (2006) Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 354:1489\u20131496","journal-title":"N Engl J Med"},{"key":"4645_CR27","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1212\/01.wnl.0000295994.46586.e7","volume":"69","author":"K Vahedi","year":"2007","unstructured":"Vahedi K, Boukobza M, Massin P, Gould DB, Tournier-Lasserve E, Bousser MG (2007) Clinical and brain MRI follow-up study of a family with COL4A1 mutation. Neurology 69:1564\u20131568","journal-title":"Neurology"},{"key":"4645_CR28","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/STROKEAHA.106.475194","volume":"38","author":"K Vahedi","year":"2007","unstructured":"Vahedi K, Kubis N, Boukobza M, Arnoult M, Massin P, Tournier-Lasserve E, Bousser MG (2007) COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage. Stroke 38:1461\u20131464","journal-title":"Stroke"},{"issue":"6","key":"4645_CR29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/ene.14183","volume":"27","author":"M Mancuso","year":"2020","unstructured":"Mancuso M, Arnold M, Bersano A, Burlina A, Chabriat H, Debette S, Enzinger C, Federico A, Filla A, Finsterer J, Hunt D, Lesnik Oberstein S, Tournier-Lasserve E, Markus HS (2020) Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. Eur J Neurol 27(6):909\u2013927","journal-title":"Eur J Neurol"},{"key":"4645_CR30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","volume":"344","author":"R El-Abassi","year":"2014","unstructured":"El-Abassi R, Singhal D, England JD (2014) Fabry\u2019s disease. J Neurol Sci 344:5\u201319","journal-title":"J Neurol Sci"},{"issue":"11","key":"4645_CR31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","volume":"162","author":"M Ries","year":"2003","unstructured":"Ries M, Ramaswami U, Parini R, Lindblad B, Whybra C, Willers I, Gal A, Beck M (2003) The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 162(11):767\u2013772","journal-title":"Eur J Pediatr"},{"issue":"11","key":"4645_CR32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38(11):750\u2013760","journal-title":"J Med Genet"},{"issue":"4","key":"4645_CR33","doi-asserted-by":"crossref","first-page":"e0193550","DOI":"10.1371\/journal.pone.0193550","volume":"13","author":"L Lavalle","year":"2018","unstructured":"Lavalle L, Thomas AS, Beaton B, Ebrahim H, Reed M, Ramaswami R, Elliott P, Mehta AB, Hughes DA (2018) Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation. PLoS One 13(4):e0193550","journal-title":"PLoS One"},{"issue":"3","key":"4645_CR34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1155\/2006\/828964","volume":"11","author":"AL Gibas","year":"2006","unstructured":"Gibas AL, Klatt R, Johnson J, Clarke JT, Katz J (2006) A survey of the pain experienced by males and females with Fabry disease. Pain Res Manag 11(3):185\u2013192","journal-title":"Pain Res Manag"},{"issue":"6","key":"4645_CR35","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s13244-018-0664-8","volume":"9","author":"S Cocozza","year":"2018","unstructured":"Cocozza S, Russo C, Pontillo G, Pisani A, Brunetti A (2018) Neuroimaging in Fabry disease: current knowledge and future directions. Insights Imaging 9(6):1077\u20131088","journal-title":"Insights Imaging"},{"key":"4645_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2350-3-10","volume":"3","author":"DP Germain","year":"2002","unstructured":"Germain DP, Avan P, Chassaing A, Bonfils P (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet 3:10","journal-title":"BMC Med Genet"},{"issue":"Suppl 1","key":"4645_CR37","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1007\/s10072-010-0314-5","volume":"31","author":"B Albano","year":"2010","unstructured":"Albano B, Dinia L, Del Sette M, Gandolfo C, Sivori G, Finocchi C (2010) Fabry disease in patients with migraine with aura. Neurol Sci 31(Suppl 1):S167\u2013S169","journal-title":"Neurol Sci"},{"issue":"3","key":"4645_CR38","first-page":"296","volume":"17","author":"C Henry","year":"2017","unstructured":"Henry C, Patel N, Shaffer W, Murphy L, Park J, Spieler B (2017) Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes-MELAS syndrome. Ochsner J 17(3):296\u2013301","journal-title":"Ochsner J"},{"key":"4645_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clineuro.2018.01.020","volume":"166","author":"J Finsterer","year":"2018","unstructured":"Finsterer J, Zarrouk-Mahjoub S (2018) Headache in mitochondrial disorders. Clin Neurol Neurosurg 166:44\u201349","journal-title":"Clin Neurol Neurosurg"},{"key":"4645_CR40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/0333102417723568","volume":"38","author":"C Vollono","year":"2018","unstructured":"Vollono C, Primiano G, Della Marca G, Losurdo A, Servidei S (2018) Migraine in mitochondrial disorders: prevalence and characteristics. Cephalalgia 38:1093\u20131106","journal-title":"Cephalalgia"},{"key":"4645_CR41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-2982.2005.01059.x","volume":"26","author":"M Sparaco","year":"2006","unstructured":"Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME (2006) Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26:361\u2013372","journal-title":"Cephalalgia"},{"issue":"4","key":"4645_CR42","doi-asserted-by":"crossref","first-page":"944","DOI":"10.5114\/aoms.2019.86061","volume":"15","author":"M Fila","year":"2019","unstructured":"Fila M, Paw\u0142owska E, Blasiak J (2019) Mitochondria in migraine pathophysiology - does epigenetics play a role? Arch Med Sci 15(4):944\u2013956","journal-title":"Arch Med Sci"},{"issue":"7","key":"4645_CR43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB et al (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47(7):476\u2013485","journal-title":"J Med Genet"},{"issue":"4","key":"4645_CR44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2006.00640.x","volume":"114","author":"S Knudsen","year":"2006","unstructured":"Knudsen S, Russell MB (2006) Increased risk of migraine in Marfan\u2019s syndrome? Acta Neurol Scand 114(4):281\u2013286","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"4645_CR45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/0333102412441091","volume":"32","author":"H Koppen","year":"2012","unstructured":"Koppen H, Vis JC, Gooiker DJ, Knudsen S, Bouma BJ, Tijssen JG, de Mol BAJM, Mulder BJM, Russell MB, Ferrari MD (2012) Aortic root pathology in Marfan syndrome increases the risk of migraine with aura. Cephalalgia 32(6):467\u2013472","journal-title":"Cephalalgia"},{"issue":"3","key":"4645_CR46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijcard.2008.05.037","volume":"136","author":"JC Vis","year":"2009","unstructured":"Vis JC, Timmermans J, Post MC, Budts W, Schepens MA, Thijs V et al (2009) Increased prevalence of migraine in Marfan syndrome. Int J Cardiol 136(3):330\u2013334","journal-title":"Int J Cardiol"},{"issue":"4","key":"4645_CR47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ccd.24635","volume":"81","author":"M Volman","year":"2013","unstructured":"Volman M, Mojadidi MK, Gevorgyan R, Kaing A, Agrawal H, Tobis J (2013) Incidence of patent foramen ovale and migraine headache in adults with congenital heart disease with no known cardiac shunts. Catheter Cardiovasc Interv 81(4):643\u2013647","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"4645_CR48","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/head.12417","volume":"54","author":"VT Martin","year":"2014","unstructured":"Martin VT, Neilson D (2014) Joint hypermobility and headache: the glue that binds the two together--part 2. Headache 54(8):1403\u20131411","journal-title":"Headache"},{"key":"4645_CR49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/B978-0-12-802973-2.00018-5","volume":"138","author":"J Strouse","year":"2016","unstructured":"Strouse J (2016) Sickle cell disease. Handb Clin Neurol 138:311\u2013324","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"4645_CR50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpeds.2007.02.015","volume":"151","author":"AE Niebanck","year":"2007","unstructured":"Niebanck AE, Pollock AN, Smith-Whitley K, Raffini LJ, Zimmerman RA, Ohene-Frempong K, Kwiatkowski JL (2007) Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr 151(1):67\u201372 72.e61","journal-title":"J Pediatr"},{"issue":"5","key":"4645_CR51","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jpeds.2014.01.001","volume":"164","author":"MM Dowling","year":"2014","unstructured":"Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN et al (2014) Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction. J Pediatr 164(5):1175\u20131180.e1171","journal-title":"J Pediatr"},{"issue":"6","key":"4645_CR52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1468-2982.2006.01092.x","volume":"26","author":"GS Silva","year":"2006","unstructured":"Silva GS, Vicari P, Figueiredo MS, Junior HC, Idagawa MH, Massaro AR (2006) Migraine-mimicking headache and sickle cell disease: a transcranial Doppler study. Cephalalgia 26(6):678\u2013683","journal-title":"Cephalalgia"},{"issue":"9","key":"4645_CR53","first-page":"CD011358","volume":"9","author":"NN Than","year":"2019","unstructured":"Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L (2019) Magnesium for treating sickle cell disease. Cochrane Database Syst Rev 9(9):CD011358","journal-title":"Cochrane Database Syst Rev"},{"key":"4645_CR54","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/brain\/120.7.1105","volume":"120","author":"F G\u00f3mez-Aranda","year":"1997","unstructured":"G\u00f3mez-Aranda F, Ca\u00f1adillas F, Mart\u00ed-Mass\u00f3 JF et al (1997) Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain 120:1105\u20131113","journal-title":"Brain"},{"key":"4645_CR55","doi-asserted-by":"crossref","unstructured":"Cifelli A, Vaithianathar L (2011) Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis (HaNDL). BMJ Case Reports, bcr0320102862","DOI":"10.1136\/bcr.03.2010.2862"},{"key":"4645_CR56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nrleng.2015.03.010","volume":"31","author":"J Bar\u00f3n","year":"2016","unstructured":"Bar\u00f3n J, Mulero P, Pedraza MI et al (2016) HaNDL syndrome: correlation between focal deficits topography and EEG or SPECT abnormalities in a series of 5 new cases. Neurolog\u00eda (English edition) 31:305\u2013310","journal-title":"Neurolog\u00eda (English edition)"},{"key":"4645_CR57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0333102412463494","volume":"33","author":"KD K\u00fcrt\u00fcnc\u00fcM","year":"2013","unstructured":"K\u00fcrt\u00fcnc\u00fcM KD, Zuliani L et al (2013) CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL). Cephalalgia 33:123\u2013129","journal-title":"Cephalalgia"},{"key":"4645_CR58","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1212\/WNL.45.9.1648","volume":"45","author":"MJ Berg","year":"1995","unstructured":"Berg MJ, Williams LS (1995) The transient syndrome of headache with neurologic deficits and CSF lymphocytosis. Neurology 45:1648\u20131165","journal-title":"Neurology"},{"key":"4645_CR59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2016.03.011","volume":"364","author":"A Bersano","year":"2016","unstructured":"Bersano A, Morbin M, Ciceri E, Bedini G, Berlit P, Herold M, Saccucci S, Fugnanesi V, Nordmeyer H, Farag\u00f2 G, Savoiardo M, Taroni F, Carriero MR, Boncoraglio Giorgio B, Perucca L, Caputi L, Parati Eugenio A, Kraemer M (2016) The diagnostic challenge of Divry van Bogaert and Sneddon syndrome: report of three cases and literature review. J Neurol Sci 364:77\u201383","journal-title":"J Neurol Sci"},{"key":"4645_CR60","doi-asserted-by":"crossref","unstructured":"Mitri F, Enk A, Bersano A, Kraemer M (2020) Livedo racemosa in neurological diseases: an update on the differential diagnoses. Eur J Neurol Jun 2011","DOI":"10.1111\/ene.14390"},{"key":"4645_CR61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/jaut.2000.0418","volume":"15","author":"C Frances","year":"2000","unstructured":"Frances C, Piette JC (2000) The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun 15:139\u2013143","journal-title":"J Autoimmun"},{"key":"4645_CR62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archneur.1997.00550130037013","volume":"54","author":"A Tourbah","year":"1997","unstructured":"Tourbah A, Piette JC, Iba-Zizen MT, Lyon-Caen O, Godeau P, Frances C (1997) The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol 54:53\u201360","journal-title":"Arch Neurol"},{"key":"4645_CR63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrneurol.2013.82","volume":"9","author":"J Dorr","year":"2013","unstructured":"Dorr J, Krautwald S, Wildemann B et al (2013) Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol 9:307\u2013316","journal-title":"Nat Rev Neurol"},{"key":"4645_CR64","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1038\/s41467-019-13593-5","volume":"10","author":"CC Gross","year":"2019","unstructured":"Gross CC, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J, Tr\u00f6scher AR, Schulte-Mecklenbeck A, Herich S, Schneider-Hohendorf T, Plate H, Kuhlmann T, Schwaninger M, Br\u00fcck W, Pawlitzki M, Laplaud DA, Loussouarn D, Parratt J, Barnett M, Buckland ME, Hardy TA, Reddel SW, Ringelstein M, D\u00f6rr J, Wildemann B, Kraemer M, Lassmann H, H\u00f6ftberger R, Beltr\u00e1n E, Dornmair K, Schwab N, Klotz L, Meuth SG, Martin-Blondel G, Wiendl H, Liblau R (2019) CD8(+) T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun 10:5779","journal-title":"Nat Commun"},{"key":"4645_CR65","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/jnnp-2016-314295","volume":"87","author":"I Kleffner","year":"2016","unstructured":"Kleffner I, Dorr J, Ringelstein M et al (2016) Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry 87:1287\u20131295","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4645_CR66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.medici.2018.01.003","volume":"53","author":"D Obelieniene","year":"2017","unstructured":"Obelieniene D, Macaityte R, Balnyte R, Pestininkaite R, Gleizniene R, Balciuniene J (2017) Characteristics of headache in relation to the manifestation of Susac syndrome. Medicina (Kaunas) 53:420\u2013425","journal-title":"Medicina (Kaunas)"},{"key":"4645_CR67","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1177\/1352458512441270","volume":"18","author":"J Wuerfel","year":"2012","unstructured":"Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W, Niendorf T, Paul F, Kleffner I, D\u00f6rr J (2012) Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler 18:1592\u20131599","journal-title":"Mult Scler"},{"key":"4645_CR68","first-page":"121","volume":"1","author":"JMR D\u00f6rr","year":"2018","unstructured":"D\u00f6rr JMR, Kr\u00e4mer M, Kleffner I (2018) Susac syndrome. A rare but important interdisciplinary differential diagnosis. DG Neurologie 1:121\u2013130","journal-title":"DG Neurologie"},{"key":"4645_CR69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000442298","volume":"41","author":"A Bersano","year":"2016","unstructured":"Bersano A, Guey S, Bedini G, Nava S, Herv\u00e9 D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJM, Braun KPJ, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E, on behalf of the European Moyamoya Disease Initiative (2016) Research progresses in understanding the pathophysiology of Moyamoya disease. Cerebrovasc Dis 41:105\u2013118","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"4645_CR70","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00415-019-09277-1","volume":"266","author":"M Kraemer","year":"2019","unstructured":"Kraemer M, Schwitalla JC, Diesner F, Aktas O, Hartung HP, Berlit P (2019) Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients. J Neurol 266(6):1421\u20131428","journal-title":"J Neurol"},{"issue":"5","key":"4645_CR71","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00415-019-09245-9","volume":"266","author":"J Graf","year":"2019","unstructured":"Graf J, Schwitalla JC, Albrecht P, Veltkamp R, Berlit P, Hartung HP, Aktas O, Kraemer M (2019) Misdiagnoses and delay of diagnoses in Moyamoya angiopathy-a large Caucasian case series. J Neurol 266(5):1153\u20131159","journal-title":"J Neurol"},{"key":"4645_CR72","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/0333102416643516","volume":"37","author":"M Kraemer","year":"2017","unstructured":"Kraemer M, Lee SI, Ayzenberg I, Schwitalla JC, Diehl RR, Berlit P, Bosche B, Katsarava Z, Obermann M (2017) Headache in Caucasian patients with Moyamoya angiopathy - a systematic cohort study. Cephalalgia 37:496\u2013500","journal-title":"Cephalalgia"},{"key":"4645_CR73","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.wneu.2012.11.018","volume":"80","author":"K Chao","year":"2013","unstructured":"Chao K, Steinberg GK (2013) Headaches in children with moyamoya disease: does revascularization help? World Neurosurg 80:512\u2013513","journal-title":"World Neurosurg"},{"key":"4645_CR74","first-page":"39","volume":"64","author":"M Bohara","year":"2015","unstructured":"Bohara M, Sugata S, Nishimuta Y, Karki P, Nagayama T, Sakamoto S, Tokimura H, Arita K (2015) Effect of revascularization on headache associated with Moyamoya disease in pediatric patients. Hiroshima J Med Sci 64:39\u201344","journal-title":"Hiroshima J Med Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04645-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:47:52Z","timestamp":1630709272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":74,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4645"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04645-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"3 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any study with human subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}